HOME>CSR>Mitsubishi Tanabe Pharma's CSR

Mitsubishi Tanabe Pharma's CSR

The Mitsubishi Tanabe Pharma Group's corporate philosophy of "contributing to the healthier lives of people around the world through the creation of pharmaceuticals" reflects universal values, and the realization of that philosophy is our social mission. The topic of corporate social responsibility is a focus of attention, and in this setting the Company needs to maintain an appropriate understanding of the changing state of affairs in society and to actively contribute to the resolution of social issues. In addition, there is a growing commitment around the world to working toward the resolution of environmental and social issues through worldwide initiatives, such as the SDGs adopted at a United Nations summit held in 2015. In this setting, companies are being called on to do more. The Group believes that it is necessary for our growth to contribute to the achievement of a sustainable society through our business activities. To that end, we have designated material issues that we need to address as materiality. Moreover, as people engaged in the activities of a pharmaceutical company, all of our officers and employees must have a strong sense of mission and a high level of ethical standards and conduct our business activities with fairness and integrity. Targeting the realization of a sustainable society in which patients and other people around the world can enjoy good health and better lifestyles, the Group is working energetically to implement CSR activities.

⇒Materiality
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/materiality.html

KAITEKI

Mitsubishi Tanabe Pharma is a member of the Mitsubishi Chemical Holdings Corporation (MCHC) Group, which is working to realize KAITEKI by providing solutions to environmental and social issues and contributing to the sustainable development of society and the Earth. KAITEKI means "the sustainable well-being of people, society and our planet Earth." The MCHC Group defines "KAITEKI management" as the integrated implementation of three types of management ? (1) management which focuses on capital efficiency, (2) management which strives to create innovation for society, and (3) management aiming to improve sustainability ? while maintaining a focus on time and opportunity. The MCHC Group calls the value created from the three kinds of management "KAITEKI value." All of the MCHC Group's activities target enhancement of KAITEKI value. We believe that enhancing KAITEKI Value will lead to the realization of KAITEKI. We promote this management approach aiming to generate revenue and develop ourselves sustainably while contributing to solving environmental and social issues as a company.

⇒For further information about KAITEKI, please see the MCHC website.
http://www.mitsubishichem-hd.co.jp/english/kaiteki_management/kaiteki/

Utilization of ISO 26000

Mitsubishi Tanabe Pharma implements CSR activities for a wide range of stakeholders, including patients, healthcare professionals, shareholders and investors, local communities, and employees. In conducting these activities, we actively utilize the ISO 26000 core subject framework as we identify issues and formulate action plans. This website also introduces specific initiatives in line with the ISO 26000 core subjects.

United Nations Global Compact

Since May 2006, MCHC has participated in the United Nations Global Compact, which is being advanced by the United Nations. As a member of the MCHC Group, Mitsubishi Tanabe Pharma respects the 10 principles of the United Nations Global Compact, which address human rights, labor, the environment, and anticorruption, and upholds these principles in its business activities as a responsible corporate citizen in line with its Corporate Behavior Charter.

Communicating with Principal Stakeholders
Patients and Their Families

On its website, the Company provides a variety of disease-related information for patients and their families so that they can acquire accurate knowledge that is useful in disease prevention and treatment.

⇒Discussions about diseases (Japanese only)
https://www.mt-pharma.co.jp/shared/show.php?url=../general/index.html#n01

We have established the Medical Information Center to handle inquiries about the Company's products. In addition, Group company Mitsubishi Tanabe Pharma America, Inc., provides information to ALS patients in the U.S. through Searchlight Support.

⇒Medical Information Center (inquiries)
https://www.mt-pharma.co.jp/e/inquiry/index.php

⇒Searchlight Support
https://www.radicava.com/patient/support/searchlight-support/

As a CSR activity, we established the Mitsubishi Tanabe Pharma Tenohira Partner Program, which provides aid for the activities of associations and support groups for patients with intractable diseases. These organizations work to improve patients' medical treatment, education, career prospects, etc., and to enhance their quality of life.

⇒Activities to Support Refractory Disease Patient Organization (Japanese only)
https://www.mt-pharma.co.jp/shared/show.php?url=../csr/support/index.html

Healthcare Professionals

We are actively providing pharmaceutical information through MRs. In addition, we have established information sites for healthcare professionals. In these ways, we are providing information regarding appropriate usage of ethical drugs. Furthermore, we provide information through the Community Pharmacist Support Net (CPS-net) for pharmacists and registered sales representatives who sell OTC products.

⇒Medical View Point (for healthcare professionals) (Japanese only)
https://medical.mt-pharma.co.jp/

⇒CPS-net (pharmacists, registered sales representatives) (Japanese only)
http://cps-net.jp/

Shareholders and Investors

The general meeting of shareholders provides an opportunity for direct communication with shareholders and investors, and we implement IR meetings for institutional investors (results briefings, business presentations, etc.), individual visits with overseas investors (U.S., Europe, Asia), and presentations for individual investors. The Fair Disclosure (FD) rules have taken effect, and in response the Company has formulated guidelines for the continuation of fair, timely, and appropriate information disclosure and the implementation of constructive dialog.

To enable individual and overseas investors to view IR meetings, video (Japanese/English slides, including audio) can be accessed from the Company's website. In addition, we have prepared a special section on our website for individual investors. We are working to communicate information about the Company in an easy-to-understand manner, including a corporate overview and our business activities.

IR Meeting

⇒General Meeting of Shareholders
https://www.mt-pharma.co.jp/shared/show.php?url=../e/ir/soukai/index.html

⇒IR Meetings (results briefings, business presentations, etc.)
https://www.mt-pharma.co.jp/shared/show.php?url=../e/ir/meeting/index.html

⇒Individual Investors (Japanese only)
https://www.mt-pharma.co.jp/shared/show.php?url=../ir/kojin/index.html

Each year, the Company issues the Mitsubishi Tanabe Pharma Corporate Report (Japanese and English), which is an integrated report (annual report) that includes not only Company financial information for shareholders and investors in Japan and overseas but also non-financial information, such as the status of pharmaceutical R&D, corporate governance, and consideration for the environment and society.

⇒Mitsubishi Tanabe Pharma Corporate Report
https://www.mt-pharma.co.jp/shared/show.php?url=../e/ir/annual/index.html

News Releases

In addition to information about decisions and events disclosed in accordance with timely disclosure rules determined by the stock exchange on which the Company's stock is listed, the Group utilizes news releases to disclose to the news media information that the Group has determined is useful for the purpose of deepening social recognition and understanding of the Group. In addition, the information disclosed to the news media is made available on the Company's website at the same time. In this way, we are working to share information for all stakeholders.

⇒News Releases
https://www.mt-pharma.co.jp/e/release/index.php

Employees

Mitsubishi Tanabe Pharma is working to further enhance its competitiveness and achieve sustained growth by focusing on its people as a management resource and giving individual employees the opportunity to demonstrate their full potential. To that end, we have established the Comprehensive Management System for Human Resources, career interviews, and a complete training system. In addition, we are taking steps to enhance mutual understanding and communication between the Company and employees, such as holding labor consultations, operating internal and external help-lines, and implementing an employee survey. Moreover, we are providing corporate information to employees by utilizing an in-house magazine and the Company intranet.

⇒Human Resources Development
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/csr-report/labor_practices/index.html

⇒Implementing Labor Consultations
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/csr-report/labor_practices/diversity.html

⇒Internal and external help lines
https://www.mt-pharma.co.jp/shared/show.php?url=../csr/report/human_rights/index.html

⇒Employee Survey
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/csr-report/labor_practices/safety.html

Local Communities

The Group has formulated the Declaration on Corporate Citizenship. Through educational activities at schools, company tours, local events, and the Mitsubishi Tanabe Historical Museum, we are fostering a better understanding of the Company, deepening communication with people in the areas where we conduct business, and striving to coexist in harmony with local communities.

⇒Declaration on Corporate Citizenship
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/csr-report/community/index.html/

⇒Exchange with Local Communities
https://www.mt-pharma.co.jp/shared/show.php?url=../e/company/csr-report/community/local_communities.html

CSR

CSR
Activities
Report
2018

CSR Activities Report 2018

PDF Download

Mitsubishi
Tanabe
Pharma
Corporate
Report
2018

Corporate Report 2018

PDF Download

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide